Rybelsus - direct healthcare professional communication (DHPC)

semaglutide

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Rybelsus (oral semaglutide): risk of medication error due to introduction of new formulation with increased bioavailability

Dissemination date: 01/08/2025

Key facts

• Medicine name:
  Rybelsus
• Active substance:
  semaglutide
• Regulatory outcome:
  Variation
• DHPC type:
  Medication error
• Human ATC codes:
  A10BJ06
• Dissemination date:
  01/08/2025